These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 24724880)
1. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. Lee D; Schroeder JR; Karschner EL; Goodwin RS; Hirvonen J; Gorelick DA; Huestis MA Am J Addict; 2014; 23(3):234-42. PubMed ID: 24724880 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults. Sullivan RM; Wallace AL; Stinson EA; Montoto KV; Kaiver CM; Wade NE; Lisdahl KM Cannabis Cannabinoid Res; 2022 Oct; 7(5):690-699. PubMed ID: 34678051 [No Abstract] [Full Text] [Related]
3. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154 [TBL] [Abstract][Full Text] [Related]
4. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Vandrey R; Smith MT; McCann UD; Budney AJ; Curran EM Drug Alcohol Depend; 2011 Aug; 117(1):38-44. PubMed ID: 21296508 [TBL] [Abstract][Full Text] [Related]
5. Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers. Haney M; Bedi G; Cooper ZD; Herrmann ES; Reed SC; Foltin RW; Kingsley PJ; Marnett LJ; Patel S Addict Biol; 2022 Jul; 27(4):e13183. PubMed ID: 35754107 [TBL] [Abstract][Full Text] [Related]
6. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Arendt M; Rosenberg R; Foldager L; Sher L; Munk-Jørgensen P Am J Addict; 2007; 16(6):461-7. PubMed ID: 18058411 [TBL] [Abstract][Full Text] [Related]
7. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Haney M; Hart CL; Vosburg SK; Comer SD; Reed SC; Foltin RW Psychopharmacology (Berl); 2008 Mar; 197(1):157-68. PubMed ID: 18161012 [TBL] [Abstract][Full Text] [Related]
8. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum. Bonnet U; Borda T; Scherbaum N; Specka M Drug Alcohol Depend; 2015 Oct; 155():302-6. PubMed ID: 26298553 [TBL] [Abstract][Full Text] [Related]
9. [Motivations for cannabis cessation, coping and adaptation strategies, and perceived benefits: impact on cannabis use relapse and abstinence]. Chauchard E; Septfons A; Chabrol H Encephale; 2013 Dec; 39(6):385-92. PubMed ID: 23928064 [TBL] [Abstract][Full Text] [Related]
10. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094 [TBL] [Abstract][Full Text] [Related]
11. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Haney M; Cooper ZD; Bedi G; Herrmann E; Comer SD; Reed SC; Foltin RW; Levin FR Addict Biol; 2019 Jul; 24(4):707-716. PubMed ID: 29659126 [TBL] [Abstract][Full Text] [Related]
12. Marijuana withdrawal in humans: effects of oral THC or divalproex. Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320 [TBL] [Abstract][Full Text] [Related]
13. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Shiffman S Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988 [TBL] [Abstract][Full Text] [Related]
14. The marijuana withdrawal syndrome: diagnosis and treatment. Haney M Curr Psychiatry Rep; 2005 Oct; 7(5):360-6. PubMed ID: 16216154 [TBL] [Abstract][Full Text] [Related]
15. Cannabis withdrawal in patients with and without opioid dependence. Chauchard E; Goncharov O; Krupitsky E; Gorelick DA Subst Abus; 2014; 35(3):230-4. PubMed ID: 24745656 [TBL] [Abstract][Full Text] [Related]
16. Cannabis withdrawal and sleep: A systematic review of human studies. Gates P; Albertella L; Copeland J Subst Abus; 2016; 37(1):255-69. PubMed ID: 25893849 [TBL] [Abstract][Full Text] [Related]
17. Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from Ecological Momentary Assessment. Buckner JD; Zvolensky MJ; Crosby RD; Wonderlich SA; Ecker AH; Richter A Drug Alcohol Depend; 2015 Feb; 147():20-5. PubMed ID: 25578250 [TBL] [Abstract][Full Text] [Related]
18. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Haughey HM; Marshall E; Schacht JP; Louis A; Hutchison KE Addiction; 2008 Oct; 103(10):1678-86. PubMed ID: 18705688 [TBL] [Abstract][Full Text] [Related]
19. Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Johnston J; Lintzeris N; Allsop DJ; Suraev A; Booth J; Carson DS; Helliwell D; Winstock A; McGregor IS Psychopharmacology (Berl); 2014 Dec; 231(24):4623-36. PubMed ID: 24880749 [TBL] [Abstract][Full Text] [Related]
20. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study. Milin R; Manion I; Dare G; Walker S J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):174-179. PubMed ID: 18176332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]